| San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More | Bruce V. Bigelow | 04/25/13 | San Diego |
| Optimer Shares Soar Amid Reports of Buyout Interest | Bruce V. Bigelow | 04/02/13 | San Diego |
| San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More | Bruce V. Bigelow | 02/21/13 | San Diego |
| On-Q-ity Raises $5M, Names GSK Vet as CEO | Arlene Weintraub | 02/15/12 | Boston |
| A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine | Bruce V. Bigelow | 12/23/11 | San Diego |
| Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships | Arlene Weintraub | 11/15/11 | New York |
| Alnylam and Glaxo Partner on RNAi for Vaccine Production | Arlene Weintraub | 11/01/11 | Boston |
| In a Detour From Device Strategy, Zogenix Edges Closer to New Drug Application | Bruce V. Bigelow | 10/27/11 | San Diego |
| Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech | Arlene Weintraub | 10/27/11 | New York |
| Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program” | Arlene Weintraub | 10/26/11 | Boston |
| Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine | Arlene Weintraub | 10/18/11 | Boston |
| OvaScience Uses Stem Cells to Revive Fertility | Arlene Weintraub | 10/12/11 | Boston |
| GSK and Unilever Among Early Adopters of BioLeap’s Technology for Creating New Molecules | Arlene Weintraub | 08/23/11 | New York |
| NPS Re-Jiggers Glaxo Partnership, Finds Value in Ultra-Orphan Diseases | Arlene Weintraub | 08/09/11 | New York |
| Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance | Arlene Weintraub | 06/20/11 | Boston |
| Atlas and Monsanto the Latest VC and Big Co. Getting Close | Ryan McBride | 04/14/11 | Boston |
| Christoph Westphal Leaving GSK’s SR One to Focus on Longwood Founders Fund | Gregory T. Huang | 04/04/11 | Boston |
| Semprus Scores $18M More to Help Improve Medical Devices | Gregory T. Huang | 12/13/10 | Boston |
| Biogen Idec Closing San Diego Center, Cadence Wins FDA Approval, Adventrx Files New Drug Application, & More San Diego Life Sciences News | Bruce V. Bigelow | 11/04/10 | San Diego |
| Japan Approves Ligand Drug | Bruce V. Bigelow | 11/02/10 | San Diego |
| Anaphore Names 2 to Board | Bruce V. Bigelow | 06/15/10 | San Diego |
| Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm | Ryan McBride | 04/21/10 | Boston |
| Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO | Ryan McBride | 03/24/10 | Boston |
| GSK Pays Synta $15M | Rebecca Zacks | 12/12/08 | Boston |
| Sirtris Gains SIRT3 Licenses from Harvard | Ryan McBride | 09/16/08 | Boston |
